Literature DB >> 9844698

[Diagnostic and therapeutic stragegies in peripheral obliterative arteriopathy: non-drug treatment].

J N Fiessinger1.   

Abstract

The therapeutic management of patients with peripheral arterial disease relies initially on the assessment of the severity of arterial insufficiency. At this stage, measurement of ankle systolic pressure plays a particularly important role, and is an essential part of the clinical examination. When the severity of ischaemia jeopardises the survival of a limb, the limitations associated with medical treatment clearly justify all steps being taken to enable the patient to benefit from revascularisation. In this often fragile host environment, endovascular techniques play an important part. As first-line procedures, they have a place within a multidisciplinary management approach, particularly since further surgical procedures, such as distal bypass, often prove necessary. For patients at the intermittent claudication stage, treatment indications become more complex. They include the functional repercussions of peripheral arterial occlusive disease and the cardiovascular prognosis for the patient, which is determined by assessing the extent of the arterial disease. Ultrasonography provides a topographical evaluation of the lesions and their haemodynamic repercussions. This investigation is crucial for screening patients who present with a lesion that may be appropriate for endovascular surgery. Ultrasonography is often programmed at the same time as arteriography. For patients with intermittent claudication, surgical revascularisation is considered only after a minimum 3-month period of medical treatment, for those who have significant functional impairment. In some instances, ultrasonographic evaluation, or even arteriography, may reveal lesions associated with a real risk of deterioration, such as arterial or popliteal aneurysm, and this constitutes the basis of the indication. The development of endovascular techniques has broadened the indications for surgical revascularisation to include patients with intermittent claudication. As a result, there has been a radical change with regard to the management of these patients, limiting the number for whom medical treatment is the only feasible solution.

Entities:  

Mesh:

Year:  1998        PMID: 9844698     DOI: 10.2165/00003495-199856003-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  23 in total

1.  The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease.

Authors:  S R Tunis; E B Bass; E P Steinberg
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

2.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

Review 3.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.

Authors:  J I Weitz; J Byrne; G P Clagett; M E Farkouh; J M Porter; D L Sackett; D E Strandness; L M Taylor
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

Review 4.  [Short occlusion of the superficial femoral artery: argument for medical treatment].

Authors:  J N Fiessinger
Journal:  J Mal Vasc       Date:  1994

5.  Selection of patients for cardiac evaluation before peripheral vascular operations.

Authors:  M T Schueppert; T F Kresowik; D C Corry; C Jacobovicz; C R Mohan; E Slaymaker; J J Hoballah; W J Sharp; M Grover-McKay; J D Corson
Journal:  J Vasc Surg       Date:  1996-05       Impact factor: 4.268

6.  Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial.

Authors:  T S Creasy; P J McMillan; E W Fletcher; J Collin; P J Morris
Journal:  Eur J Vasc Surg       Date:  1990-04

7.  Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery.

Authors:  J F Baron; O Mundler; M Bertrand; E Vicaut; E Barré; G Godet; C M Samama; P Coriat; E Kieffer; P Viars
Journal:  N Engl J Med       Date:  1994-03-10       Impact factor: 91.245

8.  Femoropopliteal stent placement: long-term results.

Authors:  M R Sapoval; A L Long; A C Raynaud; B M Beyssen; J N Fiessinger; J C Gaux
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105

9.  Screening for abdominal aortic aneurysms during lower extremity arterial evaluation in the vascular laboratory.

Authors:  Y G Wolf; S M Otis; R B Schwend; E F Bernstein
Journal:  J Vasc Surg       Date:  1995-10       Impact factor: 4.268

10.  Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.

Authors:  K A Eagle; C M Coley; J B Newell; D C Brewster; R C Darling; H W Strauss; T E Guiney; C A Boucher
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.